- TheStreet.com•6 hours ago
This innovative biotech offers investors an intriguing play on the medical marijuana business.
- Business Wire•12 hours ago
22nd Century’s “Non- or Minimally-Addictive” Cigarettes Gaining Support of Leading Tobacco Scientists around the World
22nd Century Group, Inc. , a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that leading scientists published more than 12 new studies involving 22nd Century’s Very Low Nicotine cigarettes at the 23rd Annual Meeting of the Society for Research on Nicotine & Tobacco held earlier this month in Florence, Italy.
- Business Wire•yesterday
22nd Century Invited to Speak at the Colorado Hemp Expo about the Company’s Medical Marijuana Initiatives and Zero-THC Hemp Plants
22nd Century Group, Inc. , a leader in tobacco harm reduction and cannabis research, announced today that representatives of the Company’s wholly-owned subsidiary, Botanical Genetics, have been invited to serve as featured speakers and presenters at the annual Colorado Hemp Expo at the Ranch Events Complex, 5260 Arena Circle, Loveland, Colorado on Friday, March 31, 2017, and Saturday, April 1, 2017....
XXII : Summary for 22nd Century Group, Inc. Common - Yahoo Finance
22nd Century Group, Inc. (XXII)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.16 - 1.35|
|52 Week Range||0.73 - 1.71|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|